The influence of sex on renal function decline in people with Type 2 diabetes

Diabetic Medicine

Volumn 31, Issue 9, 2014, Pages 1121-1128

  de Hauteclocque, A ^a   Ragot, S ^a   Slaoui, Y ^b   Gand, E ^c   Miot, A ^d   Sosner, P ^b,e   Halimi, J M ^f   Zaoui, P ^g   Rigalleau, V ^a,h   Roussel, R ^i,j,k,l   Saulnier, P J ^a   Hadjadj Samy, S ^a,d   Arsham, Jeffrey ^m  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c Póle DUNE   (France)

^d Endocrinologie   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ BICHAT HOSPITAL   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k Dé Partement Hospitalo Universitaire FIRE   (France)

^l CENTRE DE RECHERCHE DES CORDELIERS   (France)

^m Departement Hospitalo Universitaire FIRE ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C;

AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; INTERVIEW; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RENAL REPLACEMENT THERAPY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD; DIABETIC NEPHROPATHY; DISEASE COURSE; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ALBUMINURIA; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY; RISK FACTORS; SEX FACTORS;

EID: 84906282636     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12478     Document Type: Article

References (26)

1. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222.
2. US Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012.
3. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving H-H. Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004; 66: 1596-1605.
4. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. Br Med J 1997; 314: 783-788.
5. Keane WF, Brenner BM, De Zeeuw D, Grunfeld J-P, Mcgill J, Mitch WE et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 2003; 63: 1499-1507.
6. Savage S. Johnson Nagel N, Estacio RO, Lukken N, Schrier RW. Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 1995; 25: 836-844.
7. Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2008; 24: 1212-1219.
8. Maric C. Sex, diabetes and the kidney. Am J Physiol Ren Physiol 2009; 296: F680-F688.
9. Hadjadj S, Fumeron F, Roussel R, Saulnier P-J, Gallois Y, Ankotche A et al. Prognostic value of the insertion/deletion polymorphism of the ACE gene in Type 2 diabetic subjects: results from the non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR), diabete de type 2, nephropathie et genetique (DIAB2NEPHROGENE), and survie, diabete de type 2 et genetique (SURDIAGENE) studies. Diabetes Care 2008; 31: 1847-1852.
10. Levey AS, Stevens LA, Schmid CH. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
11. Johnson DW, Atai E, Chan M, Phoon RK, Scott C, Toussaint ND et al. KHA-CARI guideline: early chronic kidney disease: detection, prevention and management. Nephrol Carlton Vic 2013; 18: 340-350.
12. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285.
13. Skupien J, Warram JH, Smiles AM, Niewczas MA, Gohda T, Pezzolesi MG et al. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease. Kidney Int 2012; 82: 589-597.
14. Bonnet F, Gauthier E, Gin H, Hadjadj S, Halimi J-M, Hannedouche T et al. Expert consensus on management of diabetic patients with impairment of renal function. Diabetes Metab 2011; 37: S1-S25.
15. Hanai K, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T et al. Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients. Nephrol Dial Transplant 2011; 27: 1070-1075.
16. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH et al. Microalbuminuria and the risk for early progressive renal function decline in Type 1 diabetes. J Am Soc Nephrol 2007; 18: 1353-1361.
17. Altemtam N, Russell J, El Nahas M. A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant 2011; 27: 1847-1854.
18. Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, Carrara F et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013; 84: 164-173.
19. Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pr 2010; 11: 49.
20. Meguro S, Tomita M, Kabeya Y, Katsuki T, Oikawa Y, Shimada A et al. Factors associated with the decline of kidney function differ among eGFR strata in subjects with Type 2 diabetes mellitus. Int J Endocrinol 2012; 2012: 1-6.
21. Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG. Early renal function decline in Type 2 diabetes. Clin J Am Soc Nephrol 2011; 7: 78-84.
22. Mankhey RW. 17-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Ren Physiol 2004; 288: F399-F405.
23. Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes. 2007; 31: 457-465.
24. Rutkowski JM, Wang ZV, Park ASD, Zhang J, Zhang D, Hu MC et al. Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol 2013; 24: 268-282.
25. Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F et al. Plasma copeptin and renal outcomes in patients with Type 2 diabetes and albuminuria. Diabetes Care 2013; 36: 3639-3645.
26. Bardoux P, Bichet DG, Martin H, Gallois Y, Marre M, Arthus M-F et al. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant 2003; 18: 497-506.